|
|
||||||||
INNOVATIVE METHODOLOGY
1Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, and 3High Resolution Imaging Facility, University of Alabama at Birmingham, Birmingham, Alabama 35294; and 2Department of Physiology and Biophysics and Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90089
Submitted 2 December 2003 ; accepted in final form 6 April 2004
| ABSTRACT |
|---|
|
|
|---|
multiphoton excitation; fluorescence microscopy; juxtaglomerular apparatus; renin activity; quinacrine
Renin release has been extensively studied using electron microscopy (17, 26, 29), radioimmunoassays (2, 3, 12, 22), and patch-clamp techniques (8). Fluorescence imaging with quinacrine was used to identify the renin-containing part of the afferent arteriole (5) and to study the effects of hemorrhage and ischemia on renal renin content (1). Most of the available renin assays work with cumbersome and potentially inaccurate techniques, and none of the existing experimental methods allow direct visualization of renin release using time-lapse imaging in a living system. Exocytosis has been suggested as the main mechanism of renin release (8, 16, 22, 26); however, to date, this process has not been visualized.
Recently, we applied multiphoton excitation laser-scanning fluorescence microscopy to visualize the microperfused JGA (20). This imaging technique allowed us to study the function of this poorly accessible, complex cell structure in vitro, with high optical resolution. The same experimental approach was used in the present work to visualize juxtaglomerular granular cells, individual renin granules, the morphology and dynamics of renin release, and tissue renin activity using acidotropic fluorophores.
| MATERIALS AND METHODS |
|---|
|
|
|---|
All animals procedures and protocols were approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham.
Imaging renin granules and release. Afferent arterioles with attached glomeruli preparations were hand-dissected from rabbit kidneys and microperfused with 150 mM NaCl containing Ringer solution as previously described (1820). Individual preparations were transferred to a thermoregulated Lucite chamber mounted on a Leica DM IRBE inverted microscope and visualized using a x63 oil-immersion lens. In some experiments, the fluorescent membrane staining dye 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate (TMA-DPH; 1 µM, Molecular Probes, Eugene, OR) was continuously present in the arteriolar perfusate to visualize cellular structures. Acidotropic fluorophores, e.g., quinacrine (Sigma, St. Louis, MO) and LysoTracker-Red (Molecular Probes), that freely pass through cell membranes and accumulate in acidic cellular compartments, were used to selectively label renin granules. Quinacrine (25 µM) was administered to the arteriolar perfusate for up to 5 min and then washed out. For visualization of fluorescence, TMA-DPH (755 nm) or quinacrine (800 nm) was excited using a two-photon laser composed of a photo-diode pump laser (5 W, Verdi) and a mode-locked titanium-sapphire laser (Mira, both from Coherent Laser Group, Santa Clara, CA) in a Leica TCS SP confocal imaging system (Leica Microsystems, Heidelberg, Germany) equipped with an acoustooptical tunable filter (AOTF). Fluorescence emission was detected at a peak of 430 (TMA-DPH) or 510 nm (quinacrine). Images were collected and analyzed with the Leica LCS imaging software in time (xyt) series, at a rate of 1 frame/10 s, or in some experiments, 1 frame/0.8 s. Renin release was stimulated by adding 100 µM isoproterenol (Sigma) to the bathing Ringer solution or, in some experiments, by reducing arteriolar perfusion pressure to zero (stop flow). Renin release was also studied in cultured, living As4.1 cells prepared according to the supplier's instructions (ATCC, Manassas, VA). As4.1 cells are derived from a renin-expressing kidney tumor induced by tissue-specific oncogene-mediated tumorigenesis in transgenic mice, and these cells have been shown to express high levels of renin mRNA and synthesize prorenin and renin (27).
Imaging renin activity.
In some experiments, renin granules were labeled after afferent arterioles were loaded with LysoTracker-Red (5 µM) for 5 min. LysoTracker-Red was excited at 568 nm using a Kr ion laser, and fluorescence emission was detected at a peak of 590 nm. Simultaneously, the 5-(2-aminoethylamino)naphthalene-1-sulfonic acid (EDANS)- and DABCYL-conjugated fluorescent renin substrate (DABCYL-
-Abu-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr, AnaSpec, San Jose, CA) was added to the bathing solution (2 µM). In the absence of renin activity, EDANS fluorescence is quenched by the acceptor molecule DABCYL due to fluorescence resonance energy transfer (FRET). However, when cleaved by renin, the two fluorophores separate, giving rise to bright EDANS fluorescence. The EDANS- and DABCYL-conjugated fluorescent renin substrate has been developed and validated earlier (11). EDANS fluorescence emission was detected at a peak of 490 nm in response to two-photon excitation at 720 nm. Sequential scanning of LysoTracker-Red and EDANS fluorescence was performed using Leica LCS imaging software, as described above.
Immunohistochemistry. Mouse kidneys were perfusion-fixed with paraformaldehyde, and tissue sections were processed as described earlier (19). Sections were subjected to microwave antigen retrieval (for 10 min) before staining and blocked for 40 min with PBS-Tween containing 2% goat serum to lower background fluorescence. After subsequent washings in PBS, tissues were treated with a rabbit polyclonal renin antibody (m752, SLU-1017, 1:100, purchased from Dr. E. J. Brandt, Technology Transfer Office, St. Louis University, St. Louis, MO). After washing, this was followed by a 40-min incubation with Alexa 594-conjugated donkey anti-rabbit IgG (1:2,500, Molecular Probes). Sections were then counterstained with quinacrine (25 µM) for 20 min and then washed twice. Some sections were counterstained with LysoTracker-Red (Alexa 488-conjugated secondary antibody was used in these experiments) and others with quinacrine and LysoTracker-Red simultaneously. Sections were mounted with Vectashield media, containing 4,6-diamino-2-phenylindole for nuclear staining (Vector Labs). Tissue sections were examined with an Olympus IX70 inverted epifluorescence microscope using a UApo/340 x40 objective. 4,6-Diamino-2-phenylindole was excited at 357 nm, quinacrine at 403 nm, Alexa 488 at 493 nm, and Alexa 594 and LysoTracker-Red at 572 nm using excitation filters (Chroma Technology, Rockingham, VT). Images were captured using a SenSys digital camera and IPLab Spectrum software equipped with a power microtome (Signal Analytics).
| RESULTS |
|---|
|
|
|---|
|
|
|
-agonist isoproterenol, a well-characterized method of stimulating renin release, to the bathing solution (100 µM) with normal-salt intake caused the dimming and disappearance of quinacrine fluorescence from four to five individual renin granules/focal plane over the course of 10 min. Isoproterenol caused a major renin release in 15 low-salt preparations that we observed (Fig. 4). On average, 40 ± 4.2% of granules disappeared in 600 s with no detectable movement relative to the cell membrane (a complete digital video of the same preparation is available in a supplementary file at http://ajprenal.physiology.org/cgi/content/full/00420.2003/DC1). The disappearance of quinacrine fluorescence (renin release) was specific for isoproterenol, because bath superfusion with vehicle only caused no significant change in the number of granules, similar to control experiments (Fig. 4B). Release appeared to be into both the luminal and interstitial compartments of the JGA. Also, there appeared to be a quantal release of granular contents; i.e., an all-or-none phenomenon. Similar to isoproterenol, reductions in arteriolar perfusion pressure, another key stimulus for renin release, caused significant renin degranulation, visualized as a reduction in quinacrine fluorescence intensity (Fig. 4C).
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
5.5) in living juxtaglomerular cells. Indeed, quinacrine has been shown before to selectively stain the intracellular storage granules in renin-producing juxtaglomerular cells in the terminal afferent arteriole (1, 5). Quinacrine has been used to visualize phagosomes (6) and secretory vesicle release in many other organs and systems (4, 25).
In the present study, quinacrine and LysoTracker selectively labeled renin granules in juxtaglomerular granular cells in the microperfused afferent arteriole as well as in As4.1 cells, a granular cell line. Localization of quinacrine fluorescence to renin granules was based on anatomic features; i.e., fluorescence was visible only in select cells of the terminal, juxtaglomerular afferent arteriole (Fig. 1) in spherically shaped granules (Figs. 1 7). In addition, renin immunohistochemistry with subsequent quinacrine counterstaining colocalized renin granules and quinacrine fluorescence (Fig. 2). Quinacrine-labeled renin granules can be easily distinguished from the much smaller, diffusely distributed lysosomes, and the large cell nuclei that are, although to a much smaller extent, also stained with this fluorophore (Figs. 2 HREF="#F5">5). High renin states, such as a low-salt diet, can be diagnosed based on quinacrine fluorescence intensity (Fig. 3), the number of granular cells, and individual granules. It should be mentioned, however, that
2550% of the in vivo renin content of the microdissected JGA is lost due to the isolation procedure (9, 22). Therefore, we standardized and kept the duration of isolation to a minimum, and dissection was always performed at 4°C to prevent degranulation. Also, quinacrine has long been used for antimalarial, antirheumatic, contraceptive, nuclear staining, antioxidant, etc. purposes (28), and it also interacts, in high doses, with many intracellular signaling pathways, enzymes, and receptors, including phospholipase A2, NADH, and NADPH (10). Low doses of quinacrine are, however, considered safe (28), and present studies used this drug temporarily, for only 12 min of loading; after that time it was washed out. There was absolutely no indication that quinacrine, by itself, alters the number or morphology of renin granules, or release, and labeling and imaging renin granules with LysoTracker-Red, another fluorophore, appeared to give the same results (Figs. 4 and 7).
Present studies support the previous observation in embedded kidney tissue after supravital staining (1) that quinacrine fluorescence in granular cells is released when renin is released. In response to the
-agonist isoproterenol, a classic stimulus for renin release (23, 12), we observed the dimming and disappearance, but no movement, of quinacrine-labeled renin granules. The disappearance was very rapid (<0.8 s) and discrete, probably caused by a fast dilution of the dye and not by changes in intragranular pH, because quinacrine and LysoTracker fluorescence are not sensitive to wide variations in pH (data not shown). Also supportive of quinacrine/renin release, after a stimulus, there was a steady increase in quinacrine fluorescence intensity in the bath fluid around granular cells (Fig. 4C). Changes in the focal plane due to possible movements were prevented by firmly holding the glomerulus-arteriole complex with the help of a micropipette. There was no change in the position of cell nuclei or those renin granules not destined for release (see supplementary video file noted in RESULTS). The only exception occurred when a decrease in or cessation of arteriole perfusion was used as a release stimulus (Fig. 4C). Here, not the absolute number of granules but a reduction in quinacrine fluorescence intensity was analyzed as a marker of renin release, an approach that appeared to be equally useful.
The dynamics of granule disappearance are consistent with previous reports on the rate of renin release (22, 23). In control studies, we observed a discontinuous pattern of release, rarely one granule disappearing, an almost constant number of granules in cells (undisturbed release, Fig. 4B). Stimulation with isoproterenol caused four to five granules to disappear in 10 min in control tissue, but in contrast, a major renin release was observed in low-salt preparations. Several low-salt afferent arterioles released
40% of their renin content in 1015 min (Figs. 4 and 7, and supplementary video). This is an unusually enormous amount, probably due to the combined stimulatory effect of a low-salt diet and a high dose of isoproterenol used. Actually, it was our purpose to show clear, significant responses in this technical report that are easy to read. These data confirm that not only renin content but also the fraction of content released (readily releasable pool) are substantially higher in kidneys from salt-deprived animals (7).
The fast dimming and disappearance of quinacrine-labeled renin granules, the emptying of granule content, and the extracellular quinacrine cloud or flash are all classic signs of exocytosis, the main mechanism for renin release, as suggested by many investigators (8, 16, 22, 26). There was no indication of granule shrinkage or increasing quinacrine fluorescence in the cytosol, which argues against the cytosolic solubilization theory of renin release (14, 29). Absolutely no detectable movement of renin granules during release is consistent with earlier ultrastructural findings using electron microscopy (26) that a previous fusion between the cell and granule membranes exists and that the mature granules are ready and about to expel their content into the extracellular space. Previously described deep invaginations of the cellular membrane (17) might explain why and how deep-lying granules, even those close to the cell nucleus, release their content into the interstitium. Furthermore, these data are consistent with the episodic and quantal release of renin (22, 23), i.e., discharge of entire amounts of renin located in single, individual granules.
Also supportive of renin release from disappearing quinacrine-labeled granules is the finding that simultaneously with degranulation there was a detectable increase in renin activity of bath fluid around granular cells (Fig. 7). The visualization of renin activity using fluorescence microscopy is also a novelty in these studies and was performed using a newly developed (11) fluorogenic peptide substrate (analogous to assaying human immunodeficiency virus protease activity) containing a sequence of human angiotensinogen and two fluorophores. Proteolytic cleavage (renin activity) releases a fragment containing only the EDANS fluorophore, thus liberating it from the quenching effect (FRET) of the nearby DABCYL chromophore. Isoproterenol stimulation caused a steady increase in EDANS fluorescence around granular cells (Fig. 7). The majority of renin activity most likely originated from renin granules at the exposed outside of the vessel, because renin substrate was added to only the bath fluid and not to the afferent arteriole perfusate. This finding confirms previous in vivo data that juxtaglomerular granular cells secrete renin into the interstitium (15). Future studies, with renin substrate in both the arteriole lumen and bath, would allow quantification of the fraction of renin that is secreted into the vascular lumen or the interstitium.
In summary, these initial studies demonstrate the feasibility of directly observing the release and activity of renin from the JGA. This approach offers the opportunity to further our understanding of the mechanism, regulation, and dynamics of renin granule exocytosis from the JGA.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
Address for reprint requests and other correspondence: J. Peti-Peterdi, ZNI335, MC 2821, 1501 San Pablo St., Los Angeles, CA 90089-2821 (E-mail: petipete{at}usc.edu).
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
U. G. Friis, K. Madsen, P. Svenningsen, P. B.L. Hansen, A. Gulaveerasingam, F. Jorgensen, C. Aalkjaer, O. Skott, and B. L. Jensen Hypotonicity-Induced Renin Exocytosis from Juxtaglomerular Cells Requires Aquaporin-1 and Cyclooxygenase-2 J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2154 - 2161. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Seeliger, T. Wronski, M. Ladwig, L. Dobrowolski, T. Vogel, M. Godes, P. B. Persson, and B. Flemming The renin-angiotensin system and the third mechanism of renal blood flow autoregulation Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1334 - F1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Vargas, I. Toma, J. J. Kang, E. J. Meer, and J. Peti-Peterdi Activation of the Succinate Receptor GPR91 in Macula Densa Cells Causes Renin Release J. Am. Soc. Nephrol., May 1, 2009; 20(5): 1002 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peti-Peterdi, I. Toma, A. Sipos, and S. L. Vargas Multiphoton Imaging of Renal Regulatory Mechanisms Physiology, April 1, 2009; 24(2): 88 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peti-Peterdi and R. H. Chow A novel tool to visualize the cell secretory pathway. Focus on "A fluorimetry-based ssYFP secretion assay to monitor vasopressin-induced exocytosis in LLC-PK1 cells expressing aquaporin-2" Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1473 - C1473. [Full Text] [PDF] |
||||
![]() |
J. Peti-Peterdi, J. J. Kang, and I. Toma Activation of the renal renin-angiotensin system in diabetes--new concepts Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3047 - 3049. [Full Text] [PDF] |
||||
![]() |
J. J. Kang, I. Toma, A. Sipos, E. J. Meer, S. L. Vargas, and J. Peti-Peterdi The Collecting Duct Is the Major Source of Prorenin in Diabetes Hypertension, June 1, 2008; 51(6): 1597 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hanner, R. Chambrey, S. Bourgeois, E. Meer, I. Mucsi, L. Rosivall, G. E. Shull, J. N. Lorenz, D. Eladari, and J. Peti-Peterdi Increased renal renin content in mice lacking the Na+/H+ exchanger NHE2 Am J Physiol Renal Physiol, April 1, 2008; 294(4): F937 - F944. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schweda, U. Friis, C. Wagner, O. Skott, and A. Kurtz Renin Release Physiology, October 1, 2007; 22(5): 310 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, R. M. Sandoval, and B. A. Molitoris Rapid determination of renal filtration function using an optical ratiometric imaging approach Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1873 - F1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rosivall, S. Mirzahosseini, I. Toma, A. Sipos, and J. Peti-Peterdi Fluid flow in the juxtaglomerular interstitium visualized in vivo Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1241 - F1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rosivall and J. Peti-Peterdi Heterogeneity of the afferent arteriole--correlations between morphology and function Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2703 - 2707. [Full Text] [PDF] |
||||
![]() |
J. J. Kang, I. Toma, A. Sipos, F. McCulloch, and J. Peti-Peterdi Quantitative imaging of basic functions in renal (patho)physiology Am J Physiol Renal Physiol, August 1, 2006; 291(2): F495 - F502. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, R. M. Sandoval, and B. A. Molitoris Quantitative intravital microscopy using a Generalized Polarity concept for kidney studies Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1197 - C1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peti-Peterdi Multiphoton imaging of renal tissues in vitro Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1079 - F1083. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |